I am Hassan Kawtharany, MD, MSCI, an Internal Medicine resident at Saint Louis University Hospital with an academic focus on the diagnosis and treatment of cardiac amyloidosis. My research examines how biomarkers, cardiac imaging, tissue sampling, and evidence-based diagnostic pathways can improve the early and accurate recognition of amyloidosis. I have authored more than 30 peer-reviewed publications, and I have contributed to multiple clinical practice guidelines, including the 2026 American Society of Hematology guidelines on the diagnosis of AL amyloidosis. I am a member of the American College of Cardiology, American Heart Association, and American College of Physicians, and I am actively involved in collaborative clinical research in amyloidosis and cardiovascular medicine.